Join
Live feed
·
INSIDERFilingvia Quantisnow
Scinai Immunotherapeutics Ltd. logo

Director Germain Mark was granted 120,000,000 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SCNI· Scinai Immunotherapeutics Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCNI (Scinai Immunotherapeutics Ltd.) and more on Quantisnow.